NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER) S.A.S. NAGAR Welcomes Parliamentary Standing Committee June 14, 2017
Vision of NIPER, S.A.S. Nagar 2
Establishment of NIPER, S.A.S. Nagar Formed as a society on Feb. 15, 1991, under the aegis of the Ministry of Chemicals and Fertilizers [Govt. of India Gazette Notification, 26.06.1998] 3
Historical Perspective 1991 Registered as a Society 1994 First Director and core faculty joined 1996 Initiation of research activities 1998 Declared Institute of National Importance. Admission of first batch of Masters students 2000 Dedication of NIPER to the Nation 2001 Visit of Joint Parliamentary Committee First Convocation 2003 Second Convocation: Dr. A.P.J. Abdul Kalam, Visitor and Chief Guest 2004 Establishment of National Bioavailability Centre 2005 Establishment of National Toxicology Centre 2007 Amendment of NIPER Act to establish Six New NIPERs 2009 Establishment of Small and Medium Pharmaceutical Industry Centre 2016 Silver Jubilee Year 4
Governance at NIPER, S.A.S. Nagar BOARD OF GOVERNORS SENATE ACADEMIC PLANNING AND DEVELOPMENT COMMITTEE FINANCE COMMITTEE LABORATORY SERVICES, BUILDING AND WORKS COMMITTEE BOARD OF STUDIES AND RESEARCH Chairman: Eminent academician/scientist/ technologist/professional, to be nominated by the Visitor Chairman: Director, NIPER, S.A.S. Nagar Chairman: Eminent academician/scientist/ technologist, to be nominated by the BoG Chairman: Director, NIPER, S.A.S. Nagar Chairman: Director, NIPER, S.A.S. Nagar Chairman: Dean, NIPER, S.A.S. Nagar 5
Administration at NIPER, S.A.S. Nagar BoG Director Dean Academic Administration Examination HoDs Academic Departments Registrar Finance & Accounts Administration Purchase Maintenance 6
Mandate, NIPER, S.A.S. Nagar Teaching activities Research activities Interaction with industry
Activities at NIPER, S.A.S. Nagar HUMAN RESOURCE DEVELOPMENT R&D ACTIVITIES Translatio nal Research Industrial Support Societal needs 8
DISCIPLINES Academics: Interdisciplinary Courses Medicinal Chemistry Pharmaceutics Natural Products Traditional Medicine Pharmacology & Toxicology Regulatory Toxicology Pharmaceutical Analysis Biotechnology Pharmaceutical Technology (Formulations) Pharmaceutical Technology (Process Chemistry) Pharmaceutical Technology (Biotechnology) Pharmacy Practice Clinical Research Pharmacoinformatics Pharmaceutical Management Degrees Offered M. S. (Pharm.) M. Pharm. M. Tech. (Pharm.) M. B. A. (Pharm.) Ph. D. 9
Academics: Drug discovery to market Drug Discovery MEDICINAL CHEMISTRY NATURAL PRODUCTS BIOTECHNOLOGY PHARMACOINFORMATICS PHARMACOLOGY & TOXICOLOGY PHARMACEUTICAL ANALYSIS PHARMACOINFORMATICS Formulation Development PHARMACEUTICAL TECHNOLOGY PHARMACEUTICS BIOTECHNOLOGY Pre-clinical Development PHARM. MANAGEMENT PHARMACY PRACTICE Approval & Marketing Clinical Testing (Phase I) GREEN: STAGES OF DRUG DISCOVERY BLACK: DEPARTMENTS 10
Orientation of Academic Programme at NIPER NIPER KNOWLEDGE INDUSTRY Earlier trend: R&D efforts in the pharma industry were taken care of by degree holders in basic sciences Current trend: With the graduates from NIPER, S.A.S. Nagar, R&D activities are strengthened by trained manpower skilled in the nuances of pharmaceutical sciences All Masters and Ph.D. degrees at NIPER, S.A.S. Nagar, are research-based 11
Research Areas THRUST AREAS: Neglected diseases Tuberculosis Malaria Leishmaniasis (Kala Azar) OTHER AREAS Drug Discovery Biopharmaceuticals Proteomics Functional Genomics Pharmacoinformatics Diabetes and other lifestyle diseases Drug Development Formulation Development Impurity Profiling Pharmaceutical Nanotechnology 12
HRD at NIPER, S.A.S. Nagar Batch Masters MBA (Pharm.) Dec 1999 27 - Dec 2000 35 - Dec 2001 37 - Dec 2002 43 - Dec 2003 55 - July 2004* - 28 July 2005 67 29 July 2006 85 28 July 2007 87 19 July 2008 89 30 July 2009 99 34 July 2010 126 37 July 2011 147 43 July 2012 230 58 July 2013 232 52 July 2014 257 64 July 2015 167 28 July 2016 177 37 TOTAL 1960 487 Year * Semester system changed from 3 to 4. ** Till date PhD 2002 5 2003 17 2004 6 2005 16 2006 7 2007 5 2008 13 2009 11 2010 6 2011 29 2012 17 2013 26 2014 27 2015 25 2016-17** 50 TOTAL 260 13
Output at NIPER, S.A.S. Nagar Placement of graduating students is distributed over Academia (Doctoral and Postdoctoral positions) Academia (Teaching positions) Pharmaceutical industry (National) Pharmaceutical industry (International) Regulatory bodies (National & International) 14
Production Research & Development Sales & Marketing Quality Control Medico- Journalism Career Opportunities Academics Hospital Pharmacy Entrepreneurship Regulatory Affairs 15
Some of our Recruiters (Academic and Regulatory Agencies) Our graduating students have been admitted to many topranked institutes as PhD candidates, Post-doctoral Fellows and as Faculty members IITs, IISERs, IISc TIFR, NCBS CSIR labs Universities in India Universities / Institutes in USA, Europe, Australia, New Zealand Regulatory Agencies CDSCO USFDA 16
Some of our recruiters (Industry)
Output at NIPER, S.A.S. Nagar Publications Highest impact factor Patents filed Patents granted Patents licensed >2,100 40 182* 48* 07** Data till June 2017 Includes some patents at different stages of filing and those granted to other agencies as assignees * Including foreign filings / approvals ** Including one patent which has been licensed to two US - based companies. 18
Zinc Dispersible Tablets
Technology licensed out NanoCrySP is a novel Spray Drying Based method to generate solid particles containing drug nanocrystals and small molecule excipients Licensed to M/s Windlas Biotech Ltd. 20
Technology licensed out 21
Skill development at SMPIC Current Membership of SMPIC: 110 22
Amendment of NIPER Act 23
Impact of NIPER, S.A.S. Nagar S.A.S. Nagar Hajipur Guwahati Raebareli Ahmedabad Kolkata Hyderabad 24
Where do we stand vis-a-vis other institutes? MHRD NIRF 2017 Rankings (Category: Pharmacy) NIPER S.A.S. Nagar achieved the second rank
Where do we stand vis-a-vis other institutes? Degree awarding institute AAAAA IISc, Bangalore AAAA+ JNCASR, Bangalore TIFR, Mumbai NIPER, Mohali ICT, Mumbai Output (100) Impact (100) IP (125) Learning (175) Productivity (50) Total (550) 100.0 30.1 120.0 159.0 42.0 451.1 24.0 46.1 79.0 150.0 50.0 349.1 47.3 59.5 71.0 146.0 18.1 341.9 6.1 42.8 99.0 145.0 19.0 311.8 19.4 26.6 71.5 145.0 45.0 307.4 [Data from Careers360 magazine, March 2014 issue] 26
Where do we stand vis-a-vis other institutes? Degree awarding institute Year of establishment AAAAA IISc, Bangalore 1909 AAAA+ JNCASR, Bangalore 1989 TIFR, Mumbai 1945 NIPER, Mohali 1994 ICT, Mumbai 1933 27
Where do we stand vis-a-vis other institutes? [Times of India, Chandigarh 28 edition] [09.03.2015]
Where do we stand vis-a-vis other institutes? NIPER, S.A.S. Nagar was awarded Thomson Reuters Innovation Award 2011 based on The number of basic inventions published in the previous year The ratio of granted patents to basic inventions The global reach of the portfolio The overall influence of the portfolio as determined by international citations of its research 29
Other recognitions Shanti Swaroop Bhatnagar Award Ranbaxy Research Award National Bioscience Award JC Bose Fellowship DBT Young Women Scientist Award INSA Young Scientist Award Distinguished Educator and Researcher Award (AAiPS) IBM Faculty Award OPPI Award Chemical Research Society of India medal Shakuntala Amir Chand Prize (ICMR) Punjab Ratan Award Advisor, WHO expert committee on specifications for pharmaceutical preparations Member, WHO Expert advisory panel on the International Pharmacopoeia and Pharmaceutical Preparations Innocentive Award and others... Members, Fellows, National and International Science Academies 30
Promotion and coordination of basic and applied research in areas related to pharmaceutical sectors The economics of drug discovery process prevents many small-scale entrepreneurs from participation. Provision of a platform containing common facilities to scientists where the entire chain of drug discovery and development process can be carried out without the need for initial investment of capital budget. 31
Promotion and coordination of basic and applied research in areas related to pharmaceutical sectors Solution to Phase II attrition problem. Establishment of R&D hub in the drug discovery and development programme Provision of soft loans to pharmaceutical industries to carry out R&D activities with support of NIPER S.A.S. Nagar or to provide funds for collaborative research between academia and industry Industry should become a part of the R&D process right in the beginning Industry supported fellowship programmes as well as research programmes of mutual interest Inclusive participation of alumni in growth of Institute Financial support from the DoP to set up an incubator research facility for the pharmaceutical industry 32
Working with external agencies Year Gross receipts (Rs. in lakh) Sponsored Projects a Sponsored Consultancy b 2012-13 426.01 79.65 2013-14 247.95 94.77 2014-15 261.78 125.60 2015-16 336.23 134.94 2016-17 207.89 107.09 a From extramural funding agencies and industry b From industry 33
Working with the industry NIPER S.A.S. Nagar has carried out laboratory scale development of a few formulations whether on their own or as sponsored projects from the industry. Subsequently, the formulations were scaled up and commercialized by the pharmaceutical industry. A few illustrative instances are provided below: Company Alliance Formulations Cachet Pharma DSM Sinochem Alliance Formulation DSM Sinochem Promed (Sentiss) AP Organics Project details 3 rd Generation synergistic disinfectant Anti snoring formulation Amoxicillin and Clavulanic acid tablets Algard disinfectant formulation Amoxicillin and Clavulanic acid dry suspension Ophthalmic formulation Oryznol capsule formulation 34
Challenges being faced Shortage of faculty: Maintenance of optimal faculty-student ratio. Release of funds under XII Plan approved by SFC. - Approved: Rs. 249.455 cr - Released: Rs. 9.79 cr only Urgent requirements: (a) Replacement of old research equipment (b) Creation of infrastructure like lecture halls, laboratories, etc. (c) Maintenance of campus Short of Non-Plan funds every year Non-recognition of M.S. (Pharm.) degree by UGC has put the career of many students at stake. 35
Emphasis in near future Digital India E-Governance E-Tendering Electronic eye Make in India Skill development and Startups 36
NIPER, SAS Nagar is well equipped to meet all the expectations of the country in the field of Pharmaceutical Sciences and Technology We seek your blessings and support 37
Thank you! 38